Skip to main content

Carmen Tur Gomez

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Carmen Tur Gomez

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Immunogenicity: assesing the clinical relevance and risk minimization of antibodies to biopharmaceuticals. IMI Grant Agreement nº 115303

IP: Manuel Comabella Lopez
Collaborators: Carmen Tur Gomez, Nicolás Miguel Fissolo
Funding agency: The Innovative Medicines Initiative
Funding: 464328
Reference: ABIRISK_IMI2010
Duration: 01/03/2012 - 27/02/2018

Unitat de Neuroimmunologia Clínica (UNiC)

IP: Unitat de Neuroimmunologia Clínica (UNiC)
Collaborators: Susana Otero Romero, Carlos Nos Llopis, Unitat de Neuroimmunologia Clínica (UNiC), Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Carmen Tur Gomez, Unitat de Neuroimmunologia Clínica (UNiC), Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Unitat de Neuroimmunologia Clínica (UNiC), M Jesus Arevalo Navines, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo , Georgina Arrambide García
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 43680
Reference: 2009 SGR 793
Duration: 01/01/2010 - 30/04/2014

REEM - Red Española de Esclerosis Múltiple

IP: REEM - Red Española de Esclerosis Múltiple
Collaborators: Carlos Nos Llopis, REEM - Red Española de Esclerosis Múltiple, Jaume Sastre Garriga, Jordi Rio Izquierdo, Fco. Javier Aymerich Martínez, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Carmen Tur Gomez, Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Alex Rovira Cañellas, REEM - Red Española de Esclerosis Múltiple, M Jesus Arevalo Navines, Dunia Muñoz Valdivielso, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo
Funding agency: Instituto de Salud Carlos III
Funding: 364373.77
Reference: RD07/0060/0020
Duration: 01/01/2008 - 31/12/2014

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

Related professionals

Xavier Serra Ruiz

Xavier Serra Ruiz

Research technician
Physiology and Pathophysiology of the Digestive Tract
Read more
Liubovi Sopco

Liubovi Sopco

Predoctoral researcher
Neurovascular Diseases
Read more
Alvaro Garcia Del campo

Alvaro Garcia Del campo

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Juan José Palmí Perales

Juan José Palmí Perales

Research technician
Pediatric Neurology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.